Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 18,123 | 21,560 | 19,022 | 21,909 | 22,146 |
| Operating Income | -18,123 | -21,560 | -19,022 | -21,909 | -22,146 |
| Other Income | 90 | 142 | 294 | 414 | 573 |
| Pre-tax Income | -18,033 | -21,418 | -18,728 | -21,495 | -21,573 |
| Net Income Continuous | -18,033 | -21,418 | -18,728 | -21,495 | -21,573 |
| Net Income | $-18,033 | $-21,418 | $-18,728 | $-21,495 | $-21,573 |
| EPS Basic Total Ops | -7.25 | -10.00 | -14.25 | -16.25 | -16.50 |
| EPS Basic Continuous Ops | -7.24 | -10.11 | -14.15 | -16.33 | -16.40 |
| EPS Diluted Total Ops | -7.25 | -10.00 | -14.25 | -16.25 | -16.50 |
| EPS Diluted Continuous Ops | -7.24 | -10.11 | -14.15 | -16.33 | -16.40 |
| EBITDA(a) | $-17,861 | $-21,348 | $-18,916 | $-21,872 | $-22,247 |